PET-CT Imaging of Neuro-endocrine Tumors and Preliminary Clinical Evaluation

Inclusion Criteria: * Patients over 18 years * Patient who is suspected of endocrine tumors according to symptomatology, biology or imaging or pathological context (multiple endocrine neoplasia type 1) * initial staging: this includes research multifocal disease or locoregional or metastatic extension if well-differentiated neuroendocrine tumor (grade 1 et/ou 2) * Search of the primary tumor, especially in the case of the inaugural discovery of metastases * staging of a known recurrence * Search occult recurrence or suspicion of recurrence (clinical, laboratory, imaging doubtful) * Patient who have received in a lower range than 2 months of cervico-thoraco-abdominal-pelvic CT and scintigraphy in OctréoScan® * Patient who have signed an informed consent * Patient affiliated or beneficiary of regime of social security of a Member State of the European community Exclusion Criteria: * Patient with another evolutive cancer disease and/or treated for less than 5 years * Pregnant or lactating woman * Premenopausal woman without effective contraception (estrogen-progestin or intrauterine contraceptive device) * Patient unable to give their free and informed consent * Persons placed under judicial protection